Want to join the conversation?
$A 3Q15 Q&A: Leonard of Leerink asked about book-to-bill, I’m calculating a 0.94. Mike commented, yes that number is correct and we had very strong Q3 revenue. As we look at Q4, we have lot of confidence in our ability to have growth rate pick up as we’re expecting strength in market places such as pharma, diagnostics, environmental & forensics.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?